Related Experiment Video
Updated: Mar 25, 2026

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
Published on: April 3, 2021
[Central Nervous Involvement in Patients with Fukuyama Congenital Muscular Dystrophy]
1Department of Pediatrics, Tokyo Women's Medical University, School of Medicine.
Abstract:
Fukuyama congenital muscular dystrophy (FCMD), the second most common muscular dystrophy in the Japanese population, is an autosomal recessive disorder caused by mutations in the fukutin (FKTN) gene. The main features of FCMD are a combination of infantile-onset hypotonia, generalized muscle weakness, eye abnormalities and central nervous system involvement with mental retardation and seizures associated with cortical migration defects. The FKTN gene product is thought to be necessary for maintaining migrating neurons in an immature state during migration, and for supporting migration via α-dystroglycan in the central nervous system. Typical magnetic resonance imaging findings in FCMD patients are cobblestone lissencephaly and cerebellar cystic lesions. White matter abnormalities with hyperintensity on T(2)-weighted images are seen especially in younger patients and those with severe phenotypes. Most FCMD patients are mentally retarded and the level is moderate to severe, with IQs ranging from 30 to 50. In our recent study, 62% of patients developed seizures. Among them, 71% had only febrile seizures, 6% had afebrile seizures from the onset, and 22% developed afebrile seizures following febrile seizures. Most patients had seizures that were controllable with just 1 type of antiepileptic drug, but 18% had intractable seizures that must be treated with 3 medications.
Insights
Fukuyama congenital muscular dystrophy (FCMD) is a genetic disorder affecting muscle and brain development. Mutations in the FKTN gene cause FCMD, leading to intellectual disability and seizures in many patients.
Area of Science:
- Neurology
- Genetics
- Developmental Biology
Context:
- Fukuyama congenital muscular dystrophy (FCMD) is a significant genetic disorder in Japan.
- It is characterized by muscle weakness, intellectual disability, and central nervous system abnormalities.
- Mutations in the fukutin (FKTN) gene are the underlying cause of FCMD.
Purpose:
- To detail the clinical features and neurological manifestations of FCMD.
- To investigate the role of the FKTN gene product in neuronal migration and α-dystroglycan function.
- To characterize seizure types and treatment responses in FCMD patients.
Summary:
- FCMD presents with infantile hypotonia, muscle weakness, eye abnormalities, and CNS involvement including mental retardation and seizures.
- The FKTN gene product is crucial for neuronal migration and α-dystroglycan function in the CNS.
- Typical MRI findings include cobblestone lissencephaly and cerebellar cysts; white matter abnormalities are common in severe cases.
Impact:
- Provides insights into the pathogenesis of FCMD, particularly concerning neuronal development.
- Highlights the high prevalence of seizures in FCMD patients, with a notable percentage experiencing intractable epilepsy.
- Informs clinical management strategies for FCMD, emphasizing the need for multidisciplinary care addressing neurological and developmental aspects.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

